Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yansuan Jiaobenketong'an Injection in Post-cardiac Surgery Heart Failure
CTR20132349Phase 2Active
- Sponsor
- Guangzhou Zhongwei Biotechnology
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jiaobentongamine in heart failure (HF), sponsored by Guangzhou Zhongwei Biotechnology. Started Mar 2015; status: active.
02
Drugs
jiaobentongamine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on CTR20132349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132349.